- PR Newswire•29 days ago
ASX: UNS) today announced new management and Board appointments, a strategic focus on wearable injectors, and an update to its internal investigation. John Ryan, who has served as Interim Chief Executive Officer since March 2016 and Senior Vice President, General Counsel and Secretary since 2014, has been named President and Chief Executive Officer and appointed to the Board of Directors. Michael E. Kamarck, Ph.D., former President of Merck BioVentures, has also joined the Company's Board of Directors.
- Accesswire•last monthAPPROACHING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Unilife Corporation and Reminds Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / July 22, 2016 / Lundin Law PC (the "Firm") announces that a class action lawsuit has been filed against Unilife Corporation ("Unilife" or the "Company") ...
- Business Wire•last monthJuly 25 Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming Deadline in the Class Action Lawsuit Against Unilife Corporation
Law Offices of Howard G. Smith reminds investors of the upcoming July 25, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class of investors who purchased Unilife Corporation securities between February 3, 2014 and May 23, 2016, inclusive .
Unilife Corporation (UNIS)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
|Ask||3.07 x 1000|
|Day's Range||2.96 - 3.10|
|52wk Range||2.31 - 18.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-0.37|
|Avg Vol (3m)||185,239|
|Dividend & Yield||N/A (N/A)|